Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico
January 18, 2017 07:00 ET
|
Apricus Biosciences
SAN DIEGO, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that...
OSE Immunotherapeutics signs a license option agreement with Servier to develop and commercialize the product Effi-7
December 27, 2016 18:01 ET
|
OSE Immunotherapeutics
NANTES, France and PARIS, Dec. 27, 2016 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN:FR0012127173) (Mnémo:OSE), today announced that the company has entered into a worldwide license option...
Apricus Biosciences Announces the Launch of Vitaros® for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
December 27, 2016 07:00 ET
|
Apricus Biosciences
SAN DIEGO, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the...
MacroGenics Licenses Synthon’s Technology to Develop an Anti-B7-H3 ADC
December 12, 2016 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, Md. and NIJMEGEN, the Netherlands, Dec. 12, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing...
Perry Ellis International Announces Boy's Tailored Clothing License for Perry Ellis Brand
November 08, 2016 09:30 ET
|
Perry Ellis International, Inc.
MIAMI, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Perry Ellis International (Nasdaq:PERY) announced today that it has entered into a license agreement with Peerless Clothing International for boy's...
Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
September 21, 2016 07:00 ET
|
Apricus Biosciences
SAN DIEGO, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the...